Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs XPO Inc. Common Stock (XPO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs XPO Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while XPO Inc. Common Stock trades at $183.65 (market cap $21.30B). The key difference: XPO Inc. Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, XPO Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and XPO Inc. Common Stock for 1 Days on average.
| HALO | XPO | |
|---|---|---|
Market Cap | $12.58B | $21.30B |
Volume | 2,179,278 | 897,705 |
Sector | Health | Industrials |
52-Week High | $115.22 | $228.37 |
52-Week Low | $61.63 | $123.66 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $24.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About XPO Inc. Common Stock
XPO provides freight transportation services in North America and Europe. Its operations include less-than-truckload freight transportation and brokerage services supported by a technology platform.
Read more on XPO →
